ARCHIVES

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 30 | July 29, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism

June 15, 2012

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001

Is the Concept of National Chain Of Outpatient Centers Still Viable?

May 2, 1997

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003